AHE Shares Adheris Health Limited
ASX · ASXLast in our picks 2026-10-07 — not in the current list; analysis below is from that screen
Specialty consumer brand and export recovery could lift earnings if demand stabilizes.
Signal breakdown
- ▸Recovery optionality exists, but visibility remains limited.
- ▸Above 50-day MA (+3.88%)
- ▸Volume 2.13× average — accumulation
- ▾Near 52-week low (12.9% of range)
Is AHE a buy right now?
Trend: AHE is trading above the 50-day average (+30.00%), RSI 38 — neutral momentum, with a 3-month return of -27.78%.
Valuation & quality: fundamentals show net margin -12.7%.
Our screen: BUY (score 2) — Specialty consumer brand and export recovery could lift earnings if demand stabilizes.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -50.00% | +100.00% | -50.00% | +0.00% | +0.00% |
Fundamentals
Technical signals
About Adheris Health Limited
Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in the United States. The company offers THRiV, a patient engagement platform, which transforms the patient experience by harnessing predictive modeling and precision segmentation.
Sector: Healthcare · Industry: Health Information Services · United States · Website
Related Consumer Discretionary picks
Browse: all ASX stocks · Consumer Discretionary picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.